Effect of Palivizumab Treatment on Subsequent Recurrent Wheezing in Preterm Infants: Case-control Study by Scientific Committee of Recurrent Wheezing (SCREW).

Trial Profile

Effect of Palivizumab Treatment on Subsequent Recurrent Wheezing in Preterm Infants: Case-control Study by Scientific Committee of Recurrent Wheezing (SCREW).

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Oct 2013

At a glance

  • Drugs Palivizumab (Primary)
  • Indications Allergic asthma; Respiratory syncytial virus infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Apr 2012 Actual patient number (444) added as reported by ClinicalTrials.gov.
    • 02 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 02 Apr 2012 Actual end date (1 Aug 2011) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top